Journal of Family Medicine and Primary Care

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 8  |  Issue : 4  |  Page : 1465--1469

Vulvar cancer in Iran: Retrospective study over 20 years (1998-2018)


Azamosadat Mousavi, Azadeh Yousefnezhad, Mitra Modarres-Gilani, Setareh Akhavan, Shahrzad Sheikh-Hasani 
 Department of Gynecology Oncology, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

Correspondence Address:
Dr. Azadeh Yousefnezhad
Department of Gynecology Oncology, Tehran University of Medical Sciences, Tehran
Iran

Background: We did not have any data about vulvar cancer — as a fourth cause of gynecological cancer in the worldwide — in our country. Study Design: Our study is designed to evaluate the frequency, stage and outcome of patients with vulvar cancer. Materials and Methods: In this retrospective observational study, we studied patients' records with diagnosis of vulvar cancer who referred to department of gynecology oncology, Emam-Khomeini Hospital (EKH), Tehran, Iran, between January 1998 and December 2018. A total of 106 cases of vulvar cancers were found in the records of outpatient oncology clinic of medical university of Tehran university. Survival was estimated using the Kaplan-Meier analysis with SPSS version of 24. Results: Mean age of the 106 patients in the study was 59.2 years. The most site of tumor involvement was major labial (39.1%). Vulvar cancer significantly was more in multiparous (P < 0.001) and menopause patients (P < 0.001). Squamous Cell Carcinoma was the most pathology of vulvar cancer (72.2%). Ninety patients (84.9%) had surgery as a primary treatment and 48 (53.3%) of these patients received adjuvant radiotherapy or chemoradiation after surgery. Mean duration of patient's follow up was 82.4 ± 68.3 month. Five-year survival of our patients in all stages was 71%. Conclusions: Our findings are located between developed and underdeveloped countries. Our patients are diagnosed nearly in earlier stages of disease and 84.9%t of them had surgery as a primary treatment, so earlier surgery resulted in good survival of patients.


How to cite this article:
Mousavi A, Yousefnezhad A, Modarres-Gilani M, Akhavan S, Sheikh-Hasani S. Vulvar cancer in Iran: Retrospective study over 20 years (1998-2018).J Family Med Prim Care 2019;8:1465-1469


How to cite this URL:
Mousavi A, Yousefnezhad A, Modarres-Gilani M, Akhavan S, Sheikh-Hasani S. Vulvar cancer in Iran: Retrospective study over 20 years (1998-2018). J Family Med Prim Care [serial online] 2019 [cited 2019 Aug 21 ];8:1465-1469
Available from: http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=4;spage=1465;epage=1469;aulast=Mousavi;type=0